Many Americans Miss Out on Cholesterol-Lowering Medications
According to 2024 data from Yale Medicine, around 47 million Americans use daily cholesterol-lowering medications, typically statins. These drugs are crucial in preventing plaque build-up in arteries, which can lead to heart attacks and strokes if not addressed. However, researchers are alarmed that many eligible patients aren’t taking these medications.
Not Enough Patients are Using Statins
A recent study from Johns Hopkins University indicates that many patients with high cholesterol aren’t using statins or similar drugs. Closing this gap could potentially prevent almost 100,000 non-fatal heart attacks in the U.S. each year. Their findings were published in the Journal of General Internal Medicine.
Although the rate of heart attack fatalities has declined over the past five decades, deaths related to heart failure, arrhythmia, and hypertensive heart disease are rising. “Despite advances in statins and other treatments, coronary artery disease remains a top cause of death in the U.S. and worldwide,” noted a recent press release.
Heart disease is a major issue in the U.S., affecting nearly half the population due to risk factors like obesity and high blood pressure.
Earlier this year, the American Heart Association shared some alarming statistics. Someone in America dies from heart disease every 34 seconds, totaling about 2,500 deaths a day. Surprisingly, this number exceeds that of cancer and accidents combined.
While high cholesterol isn’t the sole cause of these troubling statistics, managing low-density lipoprotein (LDL) levels can certainly aid in preventing severe cardiovascular problems.
Lead researcher Dr. Seth S. Martin, a cardiologist at Johns Hopkins, emphasized that high cholesterol is a critical health issue that often goes unnoticed. Many individuals are unaware they have it, and even when diagnosed, treatment may be inadequate. It’s essential to address this to prevent serious health crises.
Potential Benefits of Statins
The team studied cardiovascular risk and LDL levels in nearly 5,000 adults between 40 and 75 years old, based on 2013-2020 health surveys. Their analysis revealed that just under half of those who had never experienced a major cardiovascular event—47%—were eligible for cholesterol medication, yet only 23% were actually taking it.
Additionally, only 68% of patients who had experienced a significant cardiovascular event were on cholesterol-lowering medication, even though all were eligible. By bridging this treatment gap, researchers estimate significant annual health improvements in the U.S., including:
- Close to 100,000 non-fatal heart attacks
- Up to 65,000 strokes
- Over 10,000 heart bypass surgeries and stent placements
This prevention effort could save U.S. patients around $30.6 billion in medical expenses each year.
Dr. G. Caleb Alexander, another study author, noted that these findings highlight ongoing issues with the quality of care for prevalent chronic conditions like high cholesterol, and addressing these could have substantial public health benefits.
The Bottom Line
If you’re eligible, taking cholesterol-lowering drugs could significantly reduce the risk of heart attacks and strokes in the U.S.
Experts suggest that improving care to match treatment guidelines might involve better patient education about the benefits of treatment and enhanced screening practices. Always discuss health concerns with your doctor, who can guide you through potential treatment options.
